Webinar Series

Mastering Quality By Design

A Comprehensive Webinar Series on QbD and DoE in Drug Development

Join us for a journey through the realm of Quality by Design (QbD) and Design of Experiments (DoE) with our dedicated webinar series, offering practical insights and real-world applications!

Delve into the intricacies of drug product development and statistical strategies alongside our interdisciplinary team of experts from Evotec's API, Drug Product Development, Quality Assurance and Pharmacometrics disciplines who are ready to share their wealth of knowledge and experience.

Explore the entire series below and sign up for the sessions that resonate with your interests!

Part 1 - Watch on Demand

Unlocking Quality by Design: A Comprehensive Introduction to QbD Principles in Drug Product Development

This first seminar aims to offer a comprehensive overview of the fundamental concepts and principles of Quality by Design (QbD), aligning with the guidelines outlined in ICHQ8, ICHQ9, and ICHQ10. Participants will gain insight into the key terminology associated with QbD. Our goal is to furnish attendees with a foundational understanding of how QbD principles are applied to Drug Product Development.

Throughout the session, attendees will be introduced to the various stages of the QbD product development cycle. They will learn how the establishment of a robust scientific understanding of product/process and the formulation of a control strategy are intricately linked to a risk-based development approach. This approach commences in the early phases of development and extends seamlessly through to the later stages of product life cycle management.

Get to Know Our Speakers

Headshot of Mirka Scarati
Evotec logo big

Mirka Scarati

Senior Research Leader, Product Development & Manufacturing

Evotec logo big

Latest update: May 2024

Biography 


With a degree in Chemistry and Pharmaceutical Technologies from the University of Pavia (Italy) in 1999, Mirka boasts a rich career in formulation development. From Pfizer Ltd (Sittingbourne, UK) to GSK (Verona, Italy), Aptuit, and Kedrion Biopharma, she has excelled in oral dosage forms and plasma-derived intravenous product development. Currently, as a key member of Evotec Verona Scientific Direction, Mirka provides invaluable technical-scientific input and consultancy to Pharmaceutical Development & Manufacturing.

Evotec logo big
Zadeo Cimarosti ORG
Evotec logo big

Zadeo Cimarosti

VP, Head of API Development and Industrialization

Evotec logo big

Latest update: May 2024

Biography


Zadeo brings over two decades of expertise in chemical development from his tenure at GSK and Aptuit. With a Chemistry degree from the University of Milan, Zadeo's career spans route scouting, development, scale-up, and technology transfer for commercial manufacturing. He has authored numerous scientific papers, including on Quality by Design, and spearheaded the implementation of API Oligonucleotides manufacture capability at Evotec.

Evotec logo big

Part 2 - Watch on Demand

QbD Success: Statistical Strategies and DoE Expertise

This webinar will focus on essential statistical services in Quality by Design applied to Drug Product development, with a particular emphasis on the expertise of our Biostatistics team in the field of Design of Experiment (DoE).

Attendees will learn how the application of advanced statistical methodologies can optimize process and product quality within the QbD framework.

Get to Know Our Speaker

Denise Federico ORG
Evotec logo big

Denise Federico

Senior Supervisor Biostatistician - Pharmacometrics

Evotec logo big

Latest update: May 2024

Biography 


Denise, at Evotec Verona since 2016, holds an MS in Bio-demographic statistics from the University of Bologna (2012) and a second-level master's in advanced biostatistics for clinical research from the University of Padova (2022). With prior experience as a programmer and statistician in diverse fields, Denise now spearheads the Biostatistics team within Evotec's Pharmacometrics department. Her team offers vital statistical support across various drug discovery and development stages, with a focus on preclinical toxicology, safety studies, in-vitro biology, bioanalysis assay development, and Chemistry, Manufacturing, and Controls (CMC).

Evotec logo big

Part 3 - Watch on Demand

Application of Design of Experiments in API Chemical Development

This webinar will focus on the application of Design of Experiment (DoE) to chemical reactions. Despite a high resistance to use statistical tools in chemistry, the DoE can have many advantages when compared to the “one factor at time” strategy, reducing the quantity of reactions and identifying the interactions between factors with the definition of the optimal conditions.

Attendees will learn how the DoE can be applied to chemical reactions and how a DoE can be planned, identifying the factors that can affect the outputs. Additionally, case studies related to API development will be presented to show the real advantages of the DoE.

Get to Know Our Speaker

Francesco Tinazzi ORG
Evotec logo big

Francesco Tinazzi

Research Expert, API Development

Evotec logo big

Latest update: May 2024

Biography


Francesco, a chemistry graduate from the University of Padova (Italy) in 1991, embarked on his career at Glaxo in Verona in 1992. Initially part of the Chemical Development Department, he honed his expertise in lab-scale chemistry and scale-up challenges. Later, as a member of the Lab Automation Team since 1997, Francesco developed and utilized automated systems for multiple and parallel reactions, enabling rapid optimization and deeper understanding of chemical processes. His profound knowledge of Quality by Design (QbD) principles and statistical tools, including principal component analysis (PCA), multivariate analysis (MVA), and experimental designs (DoE), seamlessly integrates with automated workstations for solvent/reagent screenings and process optimization. Currently, at Evotec Verona’s API Development and Manufacturing Department, Francesco oversees chemical projects from conception to pilot plant technology transfer, ensuring a smooth progression from route definition to reaction optimization.

Evotec logo big

Part 4 - Watch on Demand

Quality Risk Management

This webinar offers a high-level overview of fundamental concepts and the philosophy of Quality Risk Management (QRM) in accordance with ICHQ9 guidelines.

It is designed to equip participants with a foundational grasp of the key principles and tools of QRM specifically as they relate to drug product development. Through a real case study, attendees will gain an introductory insight into the steps of the QRM product development cycle.

Get to Know Our Speaker

Simone Tescari ORG
Evotec logo big

Simone Tescari

Quality Specialist, Quality Assurance

Evotec logo big

Latest update: May 2024

Biography


Simone, a graduate of the 5-year program in Chemistry and Pharmaceutical Technologies at the University of Padova (Italy) in 2013, pursued a PhD in Molecular Science in 2017, with several scientific publications to his credit. Following a year of consultancy in the pharmaceutical sector, Simone joined Evotec in Verona. Initially focusing on compliance, he transitioned into a Quality Assurance (QA) specialist role over the past five years. Simone excels in managing client audits, internal audits, regulatory audits, KPIs, and cross-risk assessments within a global team.

Evotec logo big

Part 5 - Watch on Demand

DoE Approach Applied to Twin Screw Wet Granulation Technology (TSWG) Platform: A Case Study

This webinar will show a case study where a 2-level fractional factorial DoE was applied during the development of a tablet formulation prepared by Twin Screw Wet Granulation (TSWG).

It aims to offer an insight to how Design of Experiment (DoE) is currently gaining increased importance as a statistical tool during the drug product development as it allows a more systematic understanding of the variables involved in formulation and manufacturing unit operations, in line with the QbD principles.

Get to Know Our Speaker

Maria Dorly Del Curto ORG
Evotec logo big

Maria Dorly Del Curto

Senior Scientist, Formulation Development

Evotec logo big

Latest update: May 2024

Biography


Dorly holds a degree in Chemistry and Pharmaceutical Technologies from the University of Pavia (Italy) and a PhD in Pharmaceutical Sciences from the University of Milan. With a career spanning Pharmacia-Upjohn, Vectorpharma, Pharmatec, Merck-Serono, Eurand, Novo-Nordisk, and now Evotec, Maria has excelled in formulation development. Her expertise includes modified release formulations for subcutaneous administration, microparticles and nanoparticles for oral and subcutaneous delivery of peptides and small proteins, and development of new oral formulations of GLP1 analogues. Maria has contributed significantly to the field through her patents, research papers, and presentations at international pharmaceutical conferences.

Evotec logo big
TODO

Development & Manufacturing Services